Can stopping lorazepam or zolpidem after prolonged use cause withdrawal-related insomnia, confusion, or delirium, especially in older adults?

Stopping prolonged lorazepam or zolpidem can cause clinically important withdrawal phenomena, especially after abrupt cessation. For a 77-year-old, the concern is particularly relevant because age-related pharmacologic sensitivity and baseline delirium susceptibility can compound the effects of rapid sedative-hypnotic withdrawal.

Clinical evidence

• Insomnia, confusion, and delirium are recognized manifestations of benzodiazepine withdrawal, including after lorazepam. Lorazepam’s relatively short duration of action can allow symptoms to emerge within about a day of stopping.
• Zolpidem discontinuation can cause rebound insomnia, often most evident on the first night after cessation. Neuropsychiatric withdrawal is less well quantified in typical-dose users but is documented: a systematic review of 43 Z-drug withdrawal reports found zolpidem represented 93% of reports and delirium occurred in 18.6%, usually starting within 4–168 hours.
• Case reports describe agitation, confusion, hallucinations, or delirium within 24 hours of abrupt zolpidem cessation or marked dose reduction, particularly after chronic or escalated use.

Why older age matters

• Older adults have reduced clearance, altered drug distribution, and greater central nervous system sensitivity. These factors, alongside higher baseline risks of cognitive impairment and delirium, make withdrawal-related confusion or delirium biologically and clinically credible.
• The excess risk attributable specifically to age has not been directly quantified in comparative studies; nonetheless, geriatric practice supports slower, closely monitored reduction.

Practical implications

• Avoid abruptly stopping either medication after regular prolonged use. Use an individualized gradual taper, with monitoring for sleep disruption, agitation, confusion, and functional decline.
• In older chronic benzodiazepine users with insomnia, an RCT found CBT for insomnia plus gradual tapering outperformed tapering alone for successful discontinuation.
• New confusion or delirium during a taper requires prompt medical assessment for withdrawal and coexisting medical precipitants.

Bottom line

• Withdrawal-related insomnia is well established, and confusion/delirium are potentially serious complications of stopping lorazepam or zolpidem—especially abruptly. At age 77, a supervised, flexible taper rather than sudden discontinuation is the prudent approach.